ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesG25.79

G25.79

Billable

Other drug induced movement disorders

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 G25.79 is a billable code used to indicate a diagnosis of other drug induced movement disorders.

Key Diagnostic Point:

G25.79 refers to movement disorders that are induced by medications, particularly those affecting the dopaminergic system. These disorders can manifest as a variety of symptoms, including tremors, rigidity, bradykinesia, and abnormal postures. The most common culprits are antipsychotic medications, which can lead to extrapyramidal symptoms (EPS) resembling Parkinson's disease. Patients may experience acute dystonic reactions, akathisia, or tardive dyskinesia, which can significantly impact their quality of life. The pathophysiology involves alterations in dopamine pathways, particularly in the basal ganglia, leading to disrupted motor control. Accurate diagnosis requires a thorough medication history and clinical evaluation to differentiate between drug-induced movement disorders and primary movement disorders like Parkinson's disease. Treatment often involves adjusting the offending medication or using adjunctive therapies to manage symptoms.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between drug-induced and primary movement disorders
  • Understanding the range of medications that can cause symptoms
  • Recognizing the overlap with Parkinson's disease symptoms
  • Need for comprehensive patient medication history

Audit Risk Factors

  • Inadequate documentation of medication history
  • Failure to specify the type of movement disorder
  • Misclassification of primary vs. drug-induced disorders
  • Lack of follow-up documentation on treatment response

Specialty Focus

Medical Specialties

Neurology

Documentation Requirements

Detailed neurological examination findings, medication history, and response to treatment.

Common Clinical Scenarios

Patients presenting with new-onset tremors after starting antipsychotic medications.

Billing Considerations

Neurologists should document the timeline of symptom onset in relation to medication changes.

Psychiatry

Documentation Requirements

Comprehensive psychiatric evaluation, including medication management and side effects.

Common Clinical Scenarios

Patients experiencing EPS after initiation of antipsychotic therapy.

Billing Considerations

Psychiatrists must clearly document the rationale for medication choices and any adjustments made.

Coding Guidelines

Inclusion Criteria

Use G25.79 When
  • According to ICD
  • 10 guidelines, G25
  • 79 should be used when the movement disorder is clearly linked to drug exposure
  • Documentation must support the diagnosis, including the specific medication involved and the timeline of symptom onset

Exclusion Criteria

Do NOT use G25.79 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

99214CPT Code

Established patient office visit, level 4

Clinical Scenario

Used when evaluating a patient with drug-induced movement disorders.

Documentation Requirements

Detailed history, examination findings, and treatment plan.

Specialty Considerations

Neurologists and psychiatrists should document the impact of medication on symptoms.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of drug-induced movement disorders, improving the ability to track and manage these conditions in clinical practice.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of drug-induced movement disorders, improving the ability to track and manage these conditions in clinical practice.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of drug-induced movement disorders, improving the ability to track and manage these conditions in clinical practice.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What medications are commonly associated with G25.79?

Common medications include antipsychotics (e.g., haloperidol, risperidone), antiemetics (e.g., metoclopramide), and certain antidepressants. It's crucial to review the patient's medication history to identify potential causes.